154 related articles for article (PubMed ID: 28742544)
1. The Marginal Costs of Adverse Drug Events Associated With Exposures to Anticoagulants and Hypoglycemic Agents During Hospitalization.
Spector WD; Limcangco R; Furukawa MF; Encinosa WE
Med Care; 2017 Sep; 55(9):856-863. PubMed ID: 28742544
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance.
Classen DC; Jaser L; Budnitz DS
Jt Comm J Qual Patient Saf; 2010 Jan; 36(1):12-21. PubMed ID: 20112660
[TBL] [Abstract][Full Text] [Related]
3. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database.
Poudel DR; Acharya P; Ghimire S; Dhital R; Bharati R
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):635-641. PubMed ID: 28233421
[TBL] [Abstract][Full Text] [Related]
4. Association of Adverse Drug Events with Hospitalization Outcomes and Costs in Older Adults in the USA using the Nationwide Readmissions Database.
Riaz M; Brown JD
Pharmaceut Med; 2019 Aug; 33(4):321-329. PubMed ID: 31933184
[TBL] [Abstract][Full Text] [Related]
5. Marginal Hospital Cost of Surgery-related Hospital-acquired Pressure Ulcers.
Spector WD; Limcangco R; Owens PL; Steiner CA
Med Care; 2016 Sep; 54(9):845-51. PubMed ID: 27219637
[TBL] [Abstract][Full Text] [Related]
6. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.
Bates DW; Spell N; Cullen DJ; Burdick E; Laird N; Petersen LA; Small SD; Sweitzer BJ; Leape LL
JAMA; 1997 Jan 22-29; 277(4):307-11. PubMed ID: 9002493
[TBL] [Abstract][Full Text] [Related]
7. Costs of adverse drug events in German hospitals--a microcosting study.
Rottenkolber D; Hasford J; Stausberg J
Value Health; 2012; 15(6):868-75. PubMed ID: 22999137
[TBL] [Abstract][Full Text] [Related]
8. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.
Shehab N; Lovegrove MC; Geller AI; Rose KO; Weidle NJ; Budnitz DS
JAMA; 2016 Nov; 316(20):2115-2125. PubMed ID: 27893129
[TBL] [Abstract][Full Text] [Related]
9. The costs of adverse drug events in community hospitals.
Hug BL; Keohane C; Seger DL; Yoon C; Bates DW
Jt Comm J Qual Patient Saf; 2012 Mar; 38(3):120-6. PubMed ID: 22435229
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
[TBL] [Abstract][Full Text] [Related]
11. Use of Medicare Administrative Claims to Identify a Population at High Risk for Adverse Drug Events and Hospital Use for Quality Improvement.
Digmann R; Thomas A; Peppercorn S; Ryan A; Zhang L; Irby K; Brock J
J Manag Care Spec Pharm; 2019 Mar; 25(3):402-410. PubMed ID: 30816813
[TBL] [Abstract][Full Text] [Related]
12. Will meaningful use electronic medical records reduce hospital costs?
Encinosa WE; Bae J
Am J Manag Care; 2013 Nov; 19(10 Spec No):eSP19-25. PubMed ID: 24511884
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with adverse drug events among older adults in emergency department.
Chen YC; Fan JS; Chen MH; Hsu TF; Huang HH; Cheng KW; Yen DH; Huang CI; Chen LK; Yang CC
Eur J Intern Med; 2014 Jan; 25(1):49-55. PubMed ID: 24200546
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
15. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
16. National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs.
Lahue BJ; Pyenson B; Iwasaki K; Blumen HE; Forray S; Rothschild JM
Am Health Drug Benefits; 2012 Nov; 5(7):1-10. PubMed ID: 24991335
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation-associated adverse drug events.
Piazza G; Nguyen TN; Cios D; Labreche M; Hohlfelder B; Fanikos J; Fiumara K; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1136-42. PubMed ID: 22114827
[TBL] [Abstract][Full Text] [Related]
18. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay.
Oderda GM; Said Q; Evans RS; Stoddard GJ; Lloyd J; Jackson K; Rublee D; Samore MH
Ann Pharmacother; 2007 Mar; 41(3):400-6. PubMed ID: 17341537
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
Trials; 2015 Jan; 16():2. PubMed ID: 25572800
[TBL] [Abstract][Full Text] [Related]
20. Emergency department visits caused by adverse drug events: results of a French survey.
Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
